Skip to content

GMP Guideline

Trusted GMP guidance written for real-world professionals

Tag: gmp guidelines

  • Home
  • gmp guidelines
  • Page 35
GMP by Industry

Role of Blood and Plasma Product GMP in Industry Specific GMP Compliance

Role of Blood and Plasma Product GMP in Industry Specific GMP Compliance The Importance of…
GMP by Industry

Role of Blood and Plasma Product GMP in Industry Specific GMP Compliance

Role of Blood and Plasma Product GMP in Industry Specific GMP Compliance Understanding the Function…
Quality Assurance under GMP

Absence of Risk Based Justification in Quality Decisions

Absence of Risk Based Justification in Quality Decisions Understanding the Absence of Risk-Based Justification in…
GMP by Industry

Blood and Plasma Product GMP in Regulated Manufacturing Systems

Blood and Plasma Product GMP in Regulated Manufacturing Systems GMP for Blood and Plasma Products…
Quality Assurance under GMP

Risk Assessments Not Updated Following Process Changes

Risk Assessments Not Updated Following Process Changes Updating Risk Assessments After Process Modifications: Ensuring Quality…
Quality Assurance under GMP

Misclassification of Risk Levels and Compliance Impact

Misclassification of Risk Levels and Compliance Impact Consequences of Misclassifying Risk Levels in Quality Risk…
GMP by Industry

Effectiveness Review Deficiencies in Herbal Product GMP Controls

Effectiveness Review Deficiencies in Herbal Product GMP Controls Addressing Effectiveness Review Deficiencies in Herbal Product…
Quality Assurance under GMP

Inspection Focus on Risk Based Quality Systems

Inspection Focus on Risk Based Quality Systems Enhancing Pharmaceutical Quality Systems through Risk-Based Inspections In…
GMP by Industry

Documentation Control Issues in Herbal Product GMP

Documentation Control Issues in Herbal Product GMP Challenges in Documentation Control for Herbal Product GMP…
Quality Assurance under GMP

Lack of Documented Risk Assessments During Audits

Lack of Documented Risk Assessments During Audits Challenges due to Unrecorded Risk Assessments During Pharmaceutical…

Posts pagination

Previous 1 … 34 35 36 … 108 Next

Recent Posts

  • Weak Integration of Laboratory Practices with Quality Systems
  • Regulatory Risks from Weak QA Governance Systems
  • Documentation Gaps in GLP and GMP Records
  • Audit Observations Related to QA Oversight Failures
  • Failure to Align Lab Practices with Regulatory Expectations

Categories

  • Documentation and Data Integrity
  • Global GMP Guidelines
  • GMP Audits and Inspections
  • GMP Basics
  • GMP by Industry
  • Pharmaceutical GMP
  • Quality Assurance under GMP
  • Quality Control under GMP
  • SOPs
  • Training and Careers
  • Uncategorized
  • Validation and Qualification
Copyright © 2026 GMP Guideline Theme: Timely News By Artify Themes.